Njaal Stray

Switching from originator infliximab to biosimilar CT-P13 compared with maintained treatment with originator infliximab (NOR-SWITCH): a 52-week, randomised, double-blind, non-inferiority trial

Kristin Kaasen Jørgensen, Inge Christoffer Olsen, Guro Løvik Goll et al. · The Lancet · 2017 · 806 citations

Pharmacy, Internal Medicine, Pharmacotherapy +11

Clinical Course in Crohn’s Disease: Results of a Norwegian Population-Based Ten-Year Follow-Up Study

Inger Camilla Solberg, Morten H. Vatn, Ole Høie et al. · Clinical Gastroenterology and Hepatology · 2007 · 701 citations

Medicine, Clinical Sciences, Internal Medicine +12

C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study

Magne Henriksen, Jørgen Jahnsen, I. Lygren et al. · Gut · 2008 · 418 citations

Medicine, Clinical Sciences, Internal Medicine +11

Incidence of Ulcerative Colitis and Indeterminate Colitis in Four Counties of Southeastern Norway, 1990–93 A Prospective Population-Based Study

Bjørn Moum, Morten H. Vatn, Anders Ekbom et al. · Scandinavian Journal of Gastroenterology · 1996 · 193 citations

Medicine, Internal Medicine, Pathology +11

Clinical Course during the 1st Year after Diagnosis in Ulcerative Colitis and Crohn's Disease: Results of a Large, Prospective Population-based Study in Southeastern Norway, 1990-93

Bjørn Moum, Anders Ekbom, Morten H. Vatn et al. · Scandinavian Journal of Gastroenterology · 1997 · 183 citations

Medicine, Clinical Sciences, Internal Medicine +16